TO: IDEAS Study Participating Sites with Central IRB Oversight
Please be advised that the IDEAS Study (ACRIN 7155) has recently amended the protocol and informed consents. Please note that the amendment and informed consents relating to the participant and dementia specialist have been approved by the central IRB, Schulman Institutional Review Board, for use with new participants (or physicians new to the study).
Schulman IRB -Approved (central) Site Principal Investigators will receive an email notification with the approval information. The email will have a direct link to the documents. You may also access your approval documents by signing into eTools single Sign-On at www.sairb.com and choosing site access.
Protocol Amendment 1, dated 09/23/2016 and the summary of changes itemizing the revisions of Amendment 1 are attached. Should you need assistance from the IDEAS Operations Center, please contact IDEAS-Regulatory@acr.org .